Cargando…
Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review
Background: Treatment of Wilson’s disease (WD), an inherited disease characterized by copper overload, is lifelong and there is the possibility that copper deficiency (CD) may occur. We systematically reviewed the literature to describe treatment patterns, symptoms and outcomes associated with CD. M...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377829/ https://www.ncbi.nlm.nih.gov/pubmed/37510170 http://dx.doi.org/10.3390/diagnostics13142424 |
_version_ | 1785079614145560576 |
---|---|
author | Litwin, Tomasz Antos, Agnieszka Bembenek, Jan Przybyłkowski, Adam Kurkowska-Jastrzębska, Iwona Skowrońska, Marta Członkowska, Anna |
author_facet | Litwin, Tomasz Antos, Agnieszka Bembenek, Jan Przybyłkowski, Adam Kurkowska-Jastrzębska, Iwona Skowrońska, Marta Członkowska, Anna |
author_sort | Litwin, Tomasz |
collection | PubMed |
description | Background: Treatment of Wilson’s disease (WD), an inherited disease characterized by copper overload, is lifelong and there is the possibility that copper deficiency (CD) may occur. We systematically reviewed the literature to describe treatment patterns, symptoms and outcomes associated with CD. Methods: Using preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, the PubMed database was searched up to 6 April 2023. Results: Across 17 articles, 20 cases of CD were described, most commonly (15 cases) in WD patients treated with zinc salts (ZS), less often on combined chelator and ZS therapy (3 cases), molybdate salts plus ZS (1), or molybdate alone (1). CD symptoms occurred insidiously, including sideroblastic anemia, neutropenia, axonal sensory neuropathy, posterior cord myelopathy and increased ratio of epileptic seizures (or epilepsy). CD diagnosis was based on symptoms and severely reduced urinary copper excretion (<20 µg/24 h [<0.3 µmol/24 h] on ZS, or <100 µg/24 h [<1.6 µmol/24 h] on chelators) with low total serum copper and ceruloplasmin. Conclusions: Awareness of CD and regular monitoring of copper metabolism is needed during WD treatment. Temporary cessation of anti-copper treatment usually reverses serum copper reductions as well as pancytopenia; however, some symptoms, especially neuropathy and myelopathy, may persist. |
format | Online Article Text |
id | pubmed-10377829 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103778292023-07-29 Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review Litwin, Tomasz Antos, Agnieszka Bembenek, Jan Przybyłkowski, Adam Kurkowska-Jastrzębska, Iwona Skowrońska, Marta Członkowska, Anna Diagnostics (Basel) Systematic Review Background: Treatment of Wilson’s disease (WD), an inherited disease characterized by copper overload, is lifelong and there is the possibility that copper deficiency (CD) may occur. We systematically reviewed the literature to describe treatment patterns, symptoms and outcomes associated with CD. Methods: Using preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, the PubMed database was searched up to 6 April 2023. Results: Across 17 articles, 20 cases of CD were described, most commonly (15 cases) in WD patients treated with zinc salts (ZS), less often on combined chelator and ZS therapy (3 cases), molybdate salts plus ZS (1), or molybdate alone (1). CD symptoms occurred insidiously, including sideroblastic anemia, neutropenia, axonal sensory neuropathy, posterior cord myelopathy and increased ratio of epileptic seizures (or epilepsy). CD diagnosis was based on symptoms and severely reduced urinary copper excretion (<20 µg/24 h [<0.3 µmol/24 h] on ZS, or <100 µg/24 h [<1.6 µmol/24 h] on chelators) with low total serum copper and ceruloplasmin. Conclusions: Awareness of CD and regular monitoring of copper metabolism is needed during WD treatment. Temporary cessation of anti-copper treatment usually reverses serum copper reductions as well as pancytopenia; however, some symptoms, especially neuropathy and myelopathy, may persist. MDPI 2023-07-20 /pmc/articles/PMC10377829/ /pubmed/37510170 http://dx.doi.org/10.3390/diagnostics13142424 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Litwin, Tomasz Antos, Agnieszka Bembenek, Jan Przybyłkowski, Adam Kurkowska-Jastrzębska, Iwona Skowrońska, Marta Członkowska, Anna Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review |
title | Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review |
title_full | Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review |
title_fullStr | Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review |
title_full_unstemmed | Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review |
title_short | Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review |
title_sort | copper deficiency as wilson’s disease overtreatment: a systematic review |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377829/ https://www.ncbi.nlm.nih.gov/pubmed/37510170 http://dx.doi.org/10.3390/diagnostics13142424 |
work_keys_str_mv | AT litwintomasz copperdeficiencyaswilsonsdiseaseovertreatmentasystematicreview AT antosagnieszka copperdeficiencyaswilsonsdiseaseovertreatmentasystematicreview AT bembenekjan copperdeficiencyaswilsonsdiseaseovertreatmentasystematicreview AT przybyłkowskiadam copperdeficiencyaswilsonsdiseaseovertreatmentasystematicreview AT kurkowskajastrzebskaiwona copperdeficiencyaswilsonsdiseaseovertreatmentasystematicreview AT skowronskamarta copperdeficiencyaswilsonsdiseaseovertreatmentasystematicreview AT członkowskaanna copperdeficiencyaswilsonsdiseaseovertreatmentasystematicreview |